Nemaura Medical Inc

Company Profile

Nemaura Medical Inc had its IPO on 2016-03-04 under the ticker symbol NMRD.

The company operates in the Healthcare sector and Medical Devices industry. Nemaura Medical Inc has a staff strength of 36 employees.

Stock update

Shares of Nemaura Medical Inc opened at $0.4 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.35 - $0.4, and closed at $0.35.

This is a -12.5% slip from the previous day's closing price.

A total volume of 87,104 shares were traded at the close of the day’s session.

In the last one week, shares of Nemaura Medical Inc have slipped by -22.74%.

Nemaura Medical Inc's Key Ratios

Nemaura Medical Inc has a market cap of $11.56 million, indicating a price to book ratio of 122.5612 and a price to sales ratio of 71.6132.

In the last 12-months Nemaura Medical Inc’s revenue was $77044 with a gross profit of $-1476392 and an EBITDA of $-8632643. The EBITDA ratio measures Nemaura Medical Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Nemaura Medical Inc’s operating margin was -11780.43% while its return on assets stood at -40.28% with a return of equity of -724.44%.

In Q2, Nemaura Medical Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 100%.

Nemaura Medical Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-0.51 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Nemaura Medical Inc’s profitability.

Nemaura Medical Inc stock is trading at a EV to sales ratio of 91.4287 and a EV to EBITDA ratio of -6.0732. Its price to sales ratio in the trailing 12-months stood at 71.6132.

Nemaura Medical Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$14.56 million

Total Liabilities

$22.27 million

Operating Cash Flow

$0

Capital Expenditure

$100412

Dividend Payout Ratio

0%

Nemaura Medical Inc ended 2023 with $14.56 million in total assets and $0 in total liabilities. Its intangible assets were valued at $14.56 million while shareholder equity stood at $-11814198.00.

Nemaura Medical Inc ended 2023 with $0 in deferred long-term liabilities, $22.27 million in other current liabilities, 28899.00 in common stock, $-51875211.00 in retained earnings and $0 in goodwill. Its cash balance stood at $10.11 million and cash and short-term investments were $10.11 million. The company’s total short-term debt was $16,942,500 while long-term debt stood at $119477.00.

Nemaura Medical Inc’s total current assets stands at $13.54 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $409648.00 compared to accounts payable of $326641.00 and inventory worth $1.75 million.

In 2023, Nemaura Medical Inc's operating cash flow was $0 while its capital expenditure stood at $100412.

Comparatively, Nemaura Medical Inc paid $0 in dividends in 2023.

Other key metrics

Current Trading Price

$0.35

52-Week High

$3.43

52-Week Low

$0.35

Analyst Target Price

$7.67

Nemaura Medical Inc stock is currently trading at $0.35 per share. It touched a 52-week high of $3.43 and a 52-week low of $3.43. Analysts tracking the stock have a 12-month average target price of $7.67.

Its 50-day moving average was $0.77 and 200-day moving average was $1.08 The short ratio stood at 1.17 indicating a short percent outstanding of 0%.

Around 4906.6% of the company’s stock are held by insiders while 1124.9% are held by institutions.